首页 › 基金 › Addis & Hill, Inc › NMRA
Addis & Hill, Inc 对 NMRA 的持仓历史
NEUMORA THERAPEUTICS INC. · 医疗保健
Addis & Hill, Inc 在 Q3 2026 的 13F 申报中披露持有 NMRA(NEUMORA THERAPEUTICS INC.)163,386 股,市值约 US$278K,约占其申报组合的 0.15%,在其申报持仓中市值排名第 28 位。 Addis & Hill, Inc 最近 11 个申报季度中有 11 个季度披露了 NMRA 持仓,最早可追溯至 Q1 2024。
最后更新: 2026-10-19 · 来源: SEC EDGAR Form 13F-HR
Addis & Hill, Inc 对 NMRA 的持仓演变
Addis & Hill, Inc 于 Q1 2024 首次披露 NMRA 持仓:314,821 股(约 US$4.2M)。 在 11 次申报中,Addis & Hill, Inc 0 次增持、2 次减持、8 次保持不变。 最近一期申报(Q3 2026)显示持股 163,386 股、市值约 US$278K。 持仓曾出现大幅变动:Q4 2024 减持约 46% (随后一个季度股价下跌 91%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q1 2024 | 314.82K | $4.19M | 新进 |
| Q2 2024 | 300.00K | $2.94M | 减持 |
| Q3 2024 | 300.00K | $3.96M | 持有 |
| Q4 2024 | 163.39K | $1.73M | 减持 |
| Q1 2025 | 163.39K | $163.39K | 持有 |
| Q2 2025 | 163.39K | $119.81K | 持有 |
| Q3 2025 | 163.39K | $290.83K | 持有 |
| Q4 2025 | 163.39K | $292.46K | 持有 |
| Q1 2026 | 163.39K | $318.60K | 持有 |
| Q2 2026 | 163.39K | $277.76K | 持有 |
| Q3 2026 | 163.39K | $277.76K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 NMRA 与 13F 数据
NMRA(NEUMORA THERAPEUTICS INC.)属于医疗保健行业。我们追踪的基金中还有 23 只申报持有 NMRA,申报仓位最大的包括:SOFTBANK GROUP CORP. (US$10.4M), MIC Capital Management UK LLP (US$7.6M), WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST (US$5.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 NMRA 的基金
- SOFTBANK GROUP CORP. 6.09M 股 · $10.35M · Q2 2026
- MIC Capital Management UK LLP 4.46M 股 · $7.58M · Q2 2026
- WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST 3.31M 股 · $5.63M · Q2 2026
- ICONIQ Capital, LLC 2.56M 股 · $4.35M · Q2 2026
- Lunate Capital Ltd 2.12M 股 · $3.61M · Q2 2026
- Boxer Capital Management, LLC 2.00M 股 · $3.40M · Q2 2026
- JOHNSON & JOHNSON 1.85M 股 · $3.14M · Q2 2026
更多关于 Addis & Hill, Inc
常见问题
How long has Addis & Hill, Inc held NMRA?
Addis & Hill, Inc has disclosed NMRA holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Addis & Hill, Inc's current position in NMRA?
As of Q3 2026, Addis & Hill, Inc holds 163.39K shares of NMRA (NEUMORA THERAPEUTICS INC.), valued at $277.76K, representing 0.15% of its reported portfolio and ranking #28.
Has Addis & Hill, Inc been buying or selling NMRA?
In the latest 13F filing (Q3 2026), Addis & Hill, Inc held unchanged its position in NMRA.
Which other funds hold NMRA?
Other major institutional holders of NMRA include SOFTBANK GROUP CORP., MIC Capital Management UK LLP, WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST, among 23 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.